Tracking Your Progress One beneficial approach is to document your progress after each dosage adjustment
Availability: Semaglutide and tirzepatide are available now , while retatrutide is still in trials (more on availability in the next section)
Meditate, pray, go on a walk, spend quality time with family and friends, journal, or make time for self-care
doi: 10.1248/bpb.b14-00505 10 MaoDCaoHShiMWangCCKwongJLiJJXet al
Emergency room visits, hospitalizations, diagnostic tests (especially gastric emptying studies for gastroparesis claims or eye examinations for NAION claims), surgical records, and ongoing treatment documentation
Retatrutide is an investigational triple agonist acting on GLP-1, GIP, and glucagon receptors, but it has not received MHRA marketing authorisation and cannot be legally prescribed in the UK